Plunkett Research Online: SYGNIS Pharma AG

SYGNIS PHARMA AG (SYGWF:GREY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

SYGNIS AG is engaged in the development of molecular biology products. It operates as a life sciences tools and reagents company. Its molecular biology market is categorized into two segments namely Genomics and Proteomics. The company’s product portfolio comprises of tools and technologies for mole.....



SYGNIS Pharma AG
Ticker: SYGWF
Exchange: GREY
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 49 62214546
Fax: 49 62214038700
Address: Waldhofer Strasse 104
Heidelberg, 69123 Germany

Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
ContactsDescription

SYGNIS AG is engaged in the development of molecular biology products. It operates as a life sciences tools and reagents company. Its molecular biology market is categorized into two segments namely Genomics and Proteomics. The company’s product portfolio comprises of tools and technologies for mole.....See More See More

Auditor: Ernst & Young GmbH Wirtschaftspruefungsgesellschaft
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: